Antiarrhythmic properties of ranolazine: A review of the current evidence
- 25 March 2015
- journal article
- review article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 187, 66-74
- https://doi.org/10.1016/j.ijcard.2015.03.324
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Use of Ranolazine in Patients with Stable Angina PectorisCardiology, 2014
- Late sodium current inhibition: the most promising antiarrhythmic principle in the near future?Current Medicinal Chemistry, 2014
- Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysisInternational Journal of Cardiology, 2013
- Angina pectoris in women: Focus on microvascular diseaseInternational Journal of Cardiology, 2013
- A Focus on Antiarrhythmic Properties of RanolazineJournal of Cardiovascular Pharmacology and Therapeutics, 2012
- Antiarrhythmic drugs for the maintenance of sinus rhythm: Risks and benefitsInternational Journal of Cardiology, 2011
- Ranolazine for chronic stable anginaThe Lancet, 2008
- Metabolic agents in the management of diabetic coronary patients: A new eraInternational Journal of Cardiology, 2008
- Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular ConditionsCirculation, 2006
- Treatment of refractory angina pectorisInternational Journal of Cardiology, 2005